Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Industry Today.
Press releases published on April 28, 2025

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update
- FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Preclinical synergistic anti-tumor activity of FHD-909 in combination with pembrolizumab and KRAS …

LifeMD to Report First Quarter 2025 Financial Results on May 6
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial …

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates
SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel …

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that a presentation …

Clearway Signs 335 MW Power Purchase Agreement with Microsoft
SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Clearway Energy Group (“Clearway”) has signed a long-term power purchase agreement (PPA) with Microsoft for the 335 megawatt (MW) Mount Storm wind farm located in Grant County, West Virginia. Mount Storm …

Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change
WINNIPEG, Manitoba, April 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announced its fourth quarter and full year 2024 financial results. Fourth Quarter 2024 Financial Highlights ( …

VirTra Sets First Quarter 2025 Conference Call for Monday, May 12, 2025 at 4:30 p.m. ET
CHANDLER, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators and firearms training simulators for the law enforcement and military markets, …

The Aqua Sculpt Truth Revealed About Cold Ice Water Diet Hack Recipe
New York, April 28, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The science behind the Aqua Sculpt Ice Water Hack and how cold water may naturally boost metabolism through thermogenesis A detailed Aqua Sculpt ingredients list with …

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced multiple presentations …

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will …

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …

Astec Announces Quarterly Dividend
CHATTANOOGA, Tenn., April 28, 2025 (GLOBE NEWSWIRE) -- Astec Industries, Inc. (NASDAQ: ASTE) announced that its Board of Directors declared a quarterly dividend of $0.13 per share. The dividend is to be paid on or about May 30, 2025, to shareholders of …

MYR Group Inc. to Attend KeyBanc Industrials & Basic Materials Conference in May
THORNTON, Colo., April 28, 2025 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United …

Woodward Reports Second Quarter Fiscal Year 2025 Results
~Results in Line with Expectations, on Track to Deliver Full-Year Guidance~ FORT COLLINS, Colo., April 28, 2025 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ: WWD) today reported financial results for its second quarter of fiscal year 2025. All amounts are …

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced new preclinical data in collaboration with Moderna on an mRNA …

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a …

Core Molding Technologies Announces Timing of First Quarter Fiscal 2025 Results
COLUMBUS, Ohio., April 28, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building …

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to therapeutically relevant targets, including many targets …

Slimjaro Side Effects Reviewed: Discover the Shocking Truth About Ingredients, Benefits & Customer Results
New York, April 28, 2025 (GLOBE NEWSWIRE) -- TL;DR: Slimjaro Side Effects Reviewed Slimjaro is a natural, non-GMO weight loss supplement developed for individuals committed to achieving sustainable fitness and wellness goals over 3, 6, or 12 months. In …

Building a Home on Your Own Land: HelloNation Calls Robert Steele of S.S. Steele Expert on Lot-Based Home Construction in Mobile, AL
MOBILE, Ala., April 28, 2025 (GLOBE NEWSWIRE) -- Understanding what goes into building a home on your own lot can significantly reduce uncertainty and lead to a more successful outcome. This is especially true for families in Mobile, Alabama, where local …